|
The Center for Therapeutic Targeting of EWS-oncoproteins
|
1U54CA231637-01
|
$12,500,000
|
|
STEGMAIER, KIMBERLY
|
DANA-FARBER CANCER INST
|
|
Center for Cancer Research Clinical Trials Support
|
ZID BC 010882
|
$8,084,537
|
$2,829,588
|
Steakley, Caryn
|
CCR (NCI)
|
|
CCR Research Nursing
|
ZID BC 011716
|
$6,647,286
|
$6,647,286
|
Steakley, Caryn
|
CCR (NCI)
|
|
An integrated approach to analyze and target EWS/FLI in Ewing sarcoma
|
1U54CA231641-01
|
$6,163,485
|
|
LESSNICK, STEPHEN
|
RESEARCH INST NATIONWIDE CHILDREN'S HOSP
|
|
The Center for Synovial Sarcoma Biology and Therapeutics
|
1U54CA231638-01
|
$5,251,652
|
|
KADOCH, CIGALL
|
DANA-FARBER CANCER INST
|
|
Cancer Center Support Grant
|
5P30CA047904-29
|
$5,129,654
|
$153,890
|
FERRIS, ROBERT
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
|
Case Comprehensive Cancer Center Support Grant
|
5P30CA043703-27
|
$4,895,515
|
$48,955
|
GERSON, STANTON
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Baylor College of Medicine Cancer Center
|
5P30CA125123-11
|
$3,253,119
|
$65,062
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Moffitt Cancer Center Support Grant
|
2P30CA076292-19
|
$2,990,966
|
$29,910
|
SELLERS, THOMAS
|
H. LEE MOFFITT CANCER CTR & RES INST
|
|
Metro-Minnesota Community Clinical Oncology Program (MM-CCOP)
|
5UG1CA189863-05
|
$2,680,381
|
$1,340,191
|
ANDERSON, DANIEL
|
HEALTHPARTNERS INSTITUTE
|
|
Cancer Center Support Grant
|
5P30CA033572-34
|
$2,446,682
|
$122,334
|
ROSEN, STEVEN
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
Indiana University Melvin and Bren Simon Cancer Center Support Grant
|
5P30CA082709-18
|
$2,184,000
|
$43,680
|
LOEHRER, PATRICK
|
INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS
|
|
Cancer Center Support Grant (CORE) Renewal
|
5P30CA023168-37
|
$1,544,675
|
$15,447
|
RATLIFF, TIMOTHY
|
PURDUE UNIVERSITY
|
|
K12CA086913 Renewal - Paul Calabresi Award in Clinical Oncology Research
|
5K12CA086913-16
|
$1,097,811
|
$219,562
|
KANE, MADELEINE
|
UNIVERSITY OF COLORADO DENVER
|
|
Development of Combination Therapies to Delay/Prevent Acquired Drug Resistance
|
1R35CA220497-01A1
|
$1,047,525
|
|
JANNE, PASI
|
DANA-FARBER CANCER INST
|
|
Towards Precision Immuno-Oncology: Unraveling the Genomic Determinants and Mechanisms Underlying Immunotherapy Efficacy and Resistance
|
1R35CA232097-01
|
$1,040,850
|
|
CHAN, TIMOTHY
|
SLOAN-KETTERING INST CAN RESEARCH
|
|
Systemic regulation of metastasis
|
1R35CA232093-01
|
$1,017,000
|
|
LYDEN, DAVID
|
WEILL MEDICAL COLL OF CORNELL UNIV
|
|
The power of extracellular vesicles in glioblastoma
|
1R35CA232103-01
|
$935,071
|
|
BREAKEFIELD, XANDRA
|
MASSACHUSETTS GENERAL HOSPITAL
|
|
Targeting undruggable RAS for cancer treatment
|
1R35CA232113-01
|
$909,182
|
|
DER, CHANNING
|
UNIV OF NORTH CAROLINA CHAPEL HILL
|
|
Chemical Proteomic Platforms for Radically Expanding Cancer Druggability
|
1R35CA231991-01
|
$876,967
|
|
CRAVATT, BENJAMIN
|
SCRIPPS RESEARCH INSTITUTE
|
|
Accelerating Transdisciplinary Epidemiology of Colorectal Cancer
|
5R35CA197735-03
|
$869,969
|
$869,969
|
OGINO, SHUJI
|
DANA-FARBER CANCER INST
|
|
Pediatric Oncology Clinical Research Training Program
|
2K12CA090433-16
|
$810,000
|
$405,000
|
POPLACK, DAVID
|
BAYLOR COLLEGE OF MEDICINE
|
|
High-speed panoramic 3D photoacoustic computed tomography of the breast
|
1R35CA220436-01A1
|
$802,428
|
|
WANG, LIHONG
|
CALIFORNIA INSTITUTE OF TECHNOLOGY
|
|
Informal caregiver burden in advanced cancer: Economic and health outcomes
|
5R01CA196576-03
|
$768,288
|
$768,288
|
SIMINOFF, LAURA
|
TEMPLE UNIV OF THE COMMONWEALTH
|
|
Clinical Nursing and Data Management Core
|
ZID BC 011089
|
$766,596
|
$38,330
|
Linehan, W. Marston
|
CCR (NCI)
|
|
Risk Stratification for and Early Detection of Liver Cancer
|
1U01CA230997-01
|
$732,726
|
|
KANWAL, FASIHA
|
BAYLOR COLLEGE OF MEDICINE
|
|
Targeting novel therapeutic vulnerabilities in LKB1 mutant tumors.
|
1R01CA219670-01A1
|
$726,766
|
|
EL-BARDEESY, NABEEL
|
MASSACHUSETTS GENERAL HOSPITAL
|
|
Attacking stress tolerance in cancer
|
1R35CA220512-01A1
|
$709,531
|
|
CHERESH, DAVID
|
UNIVERSITY OF CALIFORNIA, SAN DIEGO
|
|
Integrating genomics and the protein interactome for HPV+ head and neck cancer therapy
|
1R35CA231998-01
|
$693,376
|
|
GRANDIS, JENNIFER
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
Spectro-Holographic Instrument for Dynamic Sensing of Cancer Progression
|
1R01CA228029-01A1
|
$688,217
|
|
PERELMAN, LEV
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
(PQ5) Mitochondrial Heterogeneity in Melanoma Tumor and Immune Responses
|
1R01CA216101-01A1
|
$670,933
|
|
SHADEL, GERALD
|
SALK INSTITUTE FOR BIOLOGICAL STUDIES
|
|
Personalized Task-Based Respiratory Motion Correction for Low-Dose PET/CT
|
1R01CA224140-01A1
|
$657,758
|
|
LIU, CHI
|
YALE UNIVERSITY
|
|
Preventing Falls and Frailty in Prostate Cancer Survivors: GET FIT Prostate
|
1R01CA222605-01A1
|
$642,716
|
|
WINTERS-STONE, KERRI
|
OREGON HEALTH & SCIENCE UNIVERSITY
|
|
Systems of Support (SOS) to Increase Colon Cancer Screening and Follow-up
|
7R01CA121125-10
|
$639,706
|
$159,927
|
GREEN, BEVERLY
|
KAISER FOUNDATION RESEARCH INSTITUTE
|
|
Genetic and Dietary Interactions in MMR Deficient Colon Tumorigenesis
|
1R01CA222358-01A1
|
$635,306
|
|
AUGENLICHT, LEONARD
|
ALBERT EINSTEIN COLLEGE OF MEDICINE, INC
|
|
Using patient-derived models to understand drug responses in SCLC
|
1U01CA220323-01A1
|
$619,923
|
|
DYSON, NICHOLAS
|
MASSACHUSETTS GENERAL HOSPITAL
|
|
Clinical Trial of Watercress in Detoxification of Environmental Toxicants and Carcinogens
|
1R01CA222005-01A1
|
$612,664
|
|
HECHT, STEPHEN
|
UNIVERSITY OF MINNESOTA
|
|
Bioinformatic-Chemical Approach to Credential Molecular Targets to Combat Rapid Chemo-Radiation Resistance in SCLC
|
1U01CA231776-01
|
$611,606
|
|
MARCHIONNI, LUIGI
|
JOHNS HOPKINS UNIVERSITY
|
|
Molecular Digital CytoImaging for Leukemia Drug Screening
|
1R01CA222095-01A1
|
$605,517
|
|
VU, TOTHU
|
OREGON HEALTH & SCIENCE UNIVERSITY
|
|
Addressing Sexual Concerns in Breast Cancer Survivors: RCT of a Novel Couple-Based Intervention
|
1R01CA222124-01A1
|
$601,848
|
|
REESE, JENNIFER
|
RESEARCH INST OF FOX CHASE CAN CTR
|
|
Identifying Metabolic Dependencies of Pancreatic Cancers
|
1R35CA232124-01
|
$592,013
|
|
KIMMELMAN, ALEC
|
NEW YORK UNIVERSITY SCHOOL OF MEDICINE
|
|
Genomic and Functional Identification of Chemotherapy Resistance Mechanisms in Small Cell Lung Cancer
|
1U01CA231844-01
|
$589,596
|
|
GOVINDAN, RAMASWAMY
|
WASHINGTON UNIVERSITY
|
|
A cluster randomized trial of a primary palliative care intervention (CONNECT) for patients with advanced cancer
|
5R01CA197103-02
|
$587,798
|
$587,798
|
SCHENKER, YAEL
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
|
Identification of Chemical Probes for the Orphan Nuclear Receptor NR2F6
|
1R01CA225890-01A1
|
$577,866
|
|
SOLT, LAURA
|
SCRIPPS FLORIDA
|
|
(PQ2) PD-L1/PD-1 signals in aged hosts undergoing cancer immunotherapy
|
1R01CA231325-01
|
$572,540
|
|
CURIEL, TYLER
|
UNIVERSITY OF TEXAS HLTH SCIENCE CENTER
|
|
Targeting Lipid Unsaturation in Ovarian Cancer Stem Cells
|
1R01CA224275-01A1
|
$567,557
|
|
MATEI, DANIELA
|
NORTHWESTERN UNIVERSITY AT CHICAGO
|
|
Genetic Loss-of-Function Studies of SETD2 in Kidney Tumorigenesis
|
1R01CA223231-01A1
|
$551,891
|
|
CHENG, EMILY
|
SLOAN-KETTERING INST CAN RESEARCH
|
|
Novel approach to attenuate small cell lung cancer growth and metastasis
|
1R01CA218545-01A1
|
$532,187
|
|
NASSER, MOHD
|
UNIVERSITY OF NEBRASKA MEDICAL CENTER
|
|
Combined NGS tumor-based detection of germline Lynch syndrome mutations and prognostic classification of endometrial cancers
|
1R01CA223219-01A1
|
$531,474
|
|
GOODFELLOW, PAUL
|
OHIO STATE UNIVERSITY
|
|
Role of protein mediate fatty acid uptake in liver cancer
|
1R01CA221916-01A1
|
$527,212
|
|
STAHL, ANDREAS
|
UNIVERSITY OF CALIFORNIA BERKELEY
|
Total relevant funding to Nursing Oncology for this search: $17,458,887
|